October 25, 2022 Meeting of the Iowa Board of Pharmacy


  1. Home
  2. October 25, 2022 Meeting of the Iowa Board of Pharmacy
Meeting Time
Meeting Location

Iowa Board of Pharmacy
400 SW 8th St
Ste E
Des Moines, IA 50309
United States

Meeting Agenda

Meeting Location: The meeting will be held via Zoom and in-person at the Board of Pharmacy office.  To access the meeting, see details below:

Join Zoom Meeting:

Meeting ID: 843 3582 1615
Passcode: k4J9hK
One tap mobile
312-626-6799, 84335821615#, *382073# US (Chicago)

Board Meeting Sign In Sheet – Pharmacists and technicians may obtain 1 hour of law CE for their attendance

9:00 a.m.         Call to Order & Announcements

Public Comment Period—anyone who has submitted material for the agenda will be given an opportunity to address the Board during the particular agenda item.  A member of the public wishing to address the Board regarding a particular agenda item should raise a hand during that agenda item to be recognized. During the initial public comment period, members of the public will have the opportunity to address the Board regarding any items not on the agenda, or any agenda item if the person is unable to be present for the discussion of the particular agenda item. Acknowledgment and an opportunity to speak will be limited to 5 minutes per person, with additional time allowed at the discretion of the chairperson.

Approval of Minutes

  1. August 24, 2022 Open Session Minutes

Mandate for Electronic Transmission of Prescriptions

  1. Richard Nightingale, MD
  2. Women’s Choice Center


  1. AlixaRx’s Innovative Pharmacy Pilot Project Quarterly Report and Pilot Project Renewal Request
  2. Request to waive 657 IAC 6.7(5)”b” requiring utilization of a video surveillance system no later than July 6, 2023 – Central Iowa Compounding, Pharmacy license 762, Urbandale
  3. Request to waive 657 IAC 4.7 requiring a foreign pharmacy graduate candidate for licensure to obtain 1,500 hours of internship – Eferonia Soliman, Pharmacist-intern registration 8249, Waukee
  4. Request to waive 657 IAC 17.3(1)”c” requiring evidence of Drug Distributor Accreditation as a condition for license renewal – Americares Foundation, Wholesale Distributor license 6654, Stamford, CT
  5. Request to waive 657 IAC 17.3(1)”c” requiring evidence of Drug Distributor Accreditation as a condition for licensure – Padagis South Carolina, Wholesale Distributor license applicant, Piedmont, SC

Reports & Informational Items

  1. Executive Director’s Report
  2. Meetings and Travel
  3. Legal Update
  4. Prescription Monitoring Program (PMP) Update
  5. Board-Sponsored Medication Disposal Update
  6. Iowa Monitoring Program for Pharmacy Professionals (IMP3) Update
  7. Compliance Report
  8. Compacts 101
  9. Well-being Index for Pharmacy Personnel Report

Rules and Legislation

  1. Proposed for adoption to amend Chapter 23, “Care Facility Pharmacy Practice,” to provide a timeframe for a care facility to submit documentation to the provider pharmacy relating to the administration of vaccines provided by the pharmacy for an immunization or screening program (ARC 6421C)
  2. Proposed for adoption to amend Chapter 41, “Outsourcing Facilities,” to provide more detailed application information relating to the inspection requirement provided in Iowa Code; clarification on when a change of ownership is determined to have occurred, necessitating a license change; assessment of late penalty fees when an outsourcing facility is not timely in submitting a license change application; and assessment of a fee for written verification of a license (ARC 6422C)
  3. Proposed for adoption to amend Chapter 14, “Public Information and Inspection of Records,” to update the manner in which records are maintained by the Board and correct Iowa Code references (ARC 6423C)
  4. Proposed for adoption to amend Chapter 12, “Precursor Substances,” to provide updated application processes and correct a cross-reference (ARC 6424C)
  5. Proposed for adoption to amend Chapter 10, “Controlled Substances,” to temporarily place one substance into Schedule V of the Iowa Controlled Substances Act (ARC 6425C)
  6. Proposed for notice of intended action to amend Chapter 3, “Pharmacy Technicians,” Chapter 6, “General Pharmacy Practice,” Chapter 8, “Universal Practice Standards,” Chapter 18, “Centralized Prescription Filling and Processing," Chapter 21, “Electronic Data and Automated Systems in Pharmacy Practice,” and Chapter 39, “Expanded Practice Standards,” to implement changes to the Iowa Code during the 2022 legislative session relating to licensed nurses engaging in the practice of nursing pursuant to a pharmacist’s order and the issuance of a prescription in the name of a school district to obtain a bronchodilator, a bronchodilator and spacer, or an opioid antagonist
  7. Proposed for pre-filing to amend Iowa Code sections 124.204, 124.210, 124.212, and 124B.2 to permanently place eight substances into Schedule I, one substance into Schedule IV, one substance into Schedule V, designate one substance as a precursor substance, and move 11 Schedule I substances from 124.204(9) to 124.204(4) in response to similar action taken by the federal Drug Enforcement Administration

Closed Session Agenda—these agenda items will be handled in closed session after the conclusion of the open session agenda items. For closed session agenda items requiring final action, the Board will vote on these items in open session.

Motion to go into closed session pursuant to Iowa Code section 21.5(1)(a), to review or discuss records which are required or authorized by state or federal law to be kept confidential; pursuant to Iowa Code section 21.5(1)(d), to discuss whether to initiate licensee disciplinary investigations or proceedings; and pursuant to Iowa Code section 21.5(1)(f), to discuss the decision to be rendered in a contested case conducted according to the provisions of Iowa Code chapter 17A.

  1. Review of Closed Session Minutes – 21.5(1)(a)
    1. August 24, 2022 Closed Session Minutes
  2. Complaints and Investigative Reports – 21.5(1)(d)
  3. Notice of Hearing and Statement of Charges – 21.5(1)(d)
  4. Settlement Agreements and Final Order – 21.5(1)(f)
    1. 2022-0007 Daniel Pharmacy, License 752, Fort Dodge
    2. 2022-0008 John Daniel, RPh, License 19184, Fort Dodge
  5. Combined Statement of Charges, Settlement Agreement and Final Orders – 21.5(1)(d) & (f)

Return to Open Session

Vote on any closed session agenda items requiring final action


Meeting Agenda Document
Meeting Minutes Document